CFOROTCServices-Medical LaboratoriesFiscal year ends December 31
CapForce Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$4.03+0.53 (+15.14%)
Close on Oct 19, 2026
- Market cap
- $50.33M
- P/E (TTM)
- 0.7
- Dividend yield
- –
CapForce statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | CapForce | Industry median |
|---|---|---|
| Market Cap | $49.96M | $1.14B |
| Enterprise Value | $49.82M | $1.35B |
| PE Ratio | 0.75 | 22.72 |
| PS Ratio | 0.66 | 1.63 |
| PB Ratio | 0.67 | 3.03 |
| P/TBV Ratio | 0.67 | 4.99 |
Enterprise value
| Measure | CapForce | Industry median |
|---|---|---|
| EV / Sales | 0.65 | 1.78 |
| EV / EBITDA | 0.77 | 14.40 |
| EV / EBIT | 0.77 | 19.04 |
Income (trailing twelve months)
| Measure | CapForce | Industry median |
|---|---|---|
| Revenue | $76.20M | $561.90M |
| Operating Income | $64.63M | -$1.81M |
| Pretax Income | $65.00M | -$572.42K |
| Net Income | $62.28M | -$1.16M |
| EBITDA | $64.83M | -$20.72K |
| EPS (Diluted) | $5.38 | -$0.02 |
Margins
| Measure | CapForce | Industry median |
|---|---|---|
| Operating Margin | 84.8% | -4.45% |
| Pretax Margin | 85.3% | 1.54% |
| Profit Margin | 81.7% | -2.91% |
| EBITDA Margin | 85.1% | 2.41% |
Returns
| Measure | CapForce | Industry median |
|---|---|---|
| Return on Equity (ROE) | 146.6% | 1.84% |
| Return on Assets (ROA) | 123.4% | -3.06% |
| Return on Invested Capital (ROIC) | 121.6% | 2.11% |
| Return on Capital Employed (ROCE) | 85.3% | -0.57% |
Growth
| Measure | CapForce | Industry median |
|---|---|---|
| Revenue Growth (3Y CAGR) | 126.3% | 10.9% |
| Revenue Growth (5Y CAGR) | 48.3% | 13.2% |
Balance sheet
| Measure | CapForce | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $143.78K | $48.71M |
| Net Cash (Debt) | $143.78K | $205.49K |
| Net Cash Per Share | $0.01 | $0.01 |
| Equity (Book Value) | $74.28M | $235.16M |
| Book Value Per Share | $5.99 | $3.48 |
| Tangible Book Value | $74.23M | $703.69K |
| Working Capital | $38.84M | $30.48M |
Financial position
| Measure | CapForce | Industry median |
|---|---|---|
| Current Ratio | 4.27 | 1.40 |
| Quick Ratio | 4.25 | 1.02 |
| Interest Coverage | 6880.62 | -0.63 |
Cash flow (trailing twelve months)
| Measure | CapForce | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.52M | $3.10M |
Efficiency
| Measure | CapForce | Industry median |
|---|---|---|
| Asset Turnover | 1.51 | 0.87 |
| Revenue Per Employee | $25.40M | $228.48K |
| Profits Per Employee | $20.76M | -$8.65K |
| Employee Count | 3 | 913 |
Dividends and yields
| Measure | CapForce | Industry median |
|---|---|---|
| Earnings Yield | 124.6% | -1.25% |
Shares
| Measure | CapForce | Industry median |
|---|---|---|
| Shares Outstanding | 12,398,100 | 58,282,400 |
| Shares Change (QoQ) | 0.24% | 0.32% |
| Float | 5,601,570 | 33,780,100 |
| Shares Held by Insiders | 54.8% | 16.4% |
Scores
| Measure | CapForce | Industry median |
|---|---|---|
| Graham Number | $26.93 | $19.59 |
| Graham Upside | 568.2% | -47.5% |
| Altman Z-Score | 2.43 | 1.96 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from CapForce's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.